• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个家族中的痤疮四联症。

Acne tetrad in a family.

作者信息

Zisova L, Sakakushev B

机构信息

Department of Dermatology, University of Medicine, Plovdiv, Bulgaria.

出版信息

Folia Med (Plovdiv). 1994;36(4):51-7.

PMID:8698287
Abstract

The authors report, for the first time in Bulgarian literature, a case of acne tetrad syndrome in a family. The patients were sisters who were found to have three of the four components of the syndrome: hidradenitis suppurativa, acne conglobata, and cysta pillaris. There was no evidence or anamnestic data for perifolliculitis capitis abscedens et suffodiens. In one of the sisters the syndrome showed a more precipitate clinical picture and was combined with other skin disorders (lichen ruber planus, neurodermitis circumscripta, hirsutismus). The patients had a familial predisposition to acne and pilar cycts. The complete blood analysis, all biochemical parameters, the cytogenetic analysis and hormonal status (testosterone and estrogens) showed no deviation from normal values. The patients did not report any disturbances during their menstrual cycles. The cellular immunity in one of the sisters was depressed. The patients and their children will be closely monitored.

摘要

作者首次在保加利亚文献中报道了一个家族中的痤疮四联症病例。患者为姐妹俩,她们被发现患有该综合征四个组成部分中的三个:化脓性汗腺炎、聚合性痤疮和毛囊囊肿。没有深部穿掘性头皮毛囊周围炎的证据或既往史资料。其中一名姐妹的综合征临床表现更为急骤,且合并了其他皮肤疾病(扁平苔藓、局限性神经性皮炎、多毛症)。患者有痤疮和毛囊囊肿的家族易感性。全血细胞分析、所有生化参数、细胞遗传学分析及激素状态(睾酮和雌激素)均显示无异常值偏差。患者未报告月经周期有任何紊乱。其中一名姐妹的细胞免疫功能低下。将对患者及其子女进行密切监测。

相似文献

1
Acne tetrad in a family.一个家族中的痤疮四联症。
Folia Med (Plovdiv). 1994;36(4):51-7.
2
A case of pyoderma vegetans and the follicular occlusion triad.1例增殖性脓皮病与毛囊闭锁三联征。
J Dermatol. 1992 Jan;19(1):61-3. doi: 10.1111/j.1346-8138.1992.tb03181.x.
3
Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin.与囊肿性痤疮、化脓性汗腺炎及穿掘性毛囊周围炎相关的关节病:异维A酸治疗
Cutis. 1999 Aug;64(2):87-90.
4
Pachyonychia congenita complicated by hidradenitis suppurativa: a family study.先天性厚甲症合并化脓性汗腺炎:一项家族研究。
Br J Dermatol. 1990 Nov;123(5):663-6. doi: 10.1111/j.1365-2133.1990.tb01485.x.
5
Perifolliculitis capitis abscedens et suffodiens with hidradenitis suppurativa and nodulocystic acne treated with adalimumab.用阿达木单抗治疗的穿掘性毛囊周围炎伴化脓性汗腺炎和结节囊肿性痤疮
J Dermatol. 2021 Aug;48(8):e374-e375. doi: 10.1111/1346-8138.15945. Epub 2021 May 7.
6
Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases.穿凿性毛囊周炎伴脓肿形成的肿瘤坏死因子抑制剂治疗:病例报告及文献复习。
J Dermatol. 2019 Sep;46(9):802-807. doi: 10.1111/1346-8138.14998. Epub 2019 Jul 4.
7
Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy.化脓性汗腺炎和聚合性痤疮与脊柱关节病相关。
Am J Med Sci. 2001 Mar;321(3):195-7. doi: 10.1097/00000441-200103000-00007.
8
Should hidradenitis suppurativa/acne inversa best be renamed as "dissecting terminal hair folliculitis"?化脓性汗腺炎/反向痤疮是否应更名为“毛囊破坏性汗腺炎”?
Exp Dermatol. 2017 Jun;26(6):544-547. doi: 10.1111/exd.13211. Epub 2017 Jan 24.
9
A case of and acne conglobata effectively treated with a tumor necrosis factor α inhibitor.一例聚合性痤疮经肿瘤坏死因子α抑制剂有效治疗的病例。 (你提供的原文“A case of and acne conglobata effectively treated with a tumor necrosis factor α inhibitor.”中“a case of”后面似乎少了些内容,我按照正常理解进行了翻译。)
Dermatol Reports. 2023 Jun 5;15(3):9699. doi: 10.4081/dr.2023.9699. eCollection 2023 Sep 12.
10
Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?坏疽性脓皮病、痤疮、化脓性汗腺炎(PASH)与多囊卵巢综合征:是巧合还是存在病因学关联?
Australas J Dermatol. 2017 May;58(2):e54-e59. doi: 10.1111/ajd.12438. Epub 2016 Feb 2.